Copyright ©  Gaffney Events. All rights reserved.

Symposium Overview

Target Audience

Symposium OBJECTIVES

The 4th Annual Mount Sinai Advanced INNOVATIONS in Heart Failure Symposium is a one-day intensive state-of-the-art review of heart failure and advanced cardiac care consisting of case reviews, didactic lectures, and expert panel discussions of emerging topics in heart failure, mechanical circulatory support and cardiac transplantation, showcasing the relevant clinical and research expertise at Mount Sinai Heart. 




The 2019 Mount Sinai Advanced INNOVATIONS in Heart Failure Symposium has been designed to meet the educational needs of General and Sub-Specialized Cardiologists, Cardiothoracic Surgeons, Nurses, Nurse Practitioners, Transplant Professionals, Fellows in Training, VAD Coordinators and Ancillary Staff committed to caring for complex cardiac patients.





At the end of this CME activity participants should be able to:

  • Describe the contemporary approach to quantify and manage secondary mitral regurgitation
  • Describe the emerging role of SGLT2 inhibitors for treating patients with diabetes and heart failure
  • Describe the role of multi-modal imaging for the diagnosis of cardiac amyloidosis
  • Describe new drug therapies for the treatment of cardiac amyloidosis
  • Review ongoing drug and device trials for patients with heart failure and preserved ejection fraction
  • Review the impact of atrial fibrillation on heart failure clinical outcomes
  • Review the role of atrial fibrillation ablation in patients with heart failure
  • Describe the hemodynamic changes that occur in cardiogenic shock and how these changes are impacted by currently available drugs and devices
  • Review the indications for and clinical outcomes with the use of temporary mechanical circulatory support devices in cardiogenic shock
  • Review the diagnosis and contemporary management of cardio-renal syndrome
  • Describe the clinical challenge of hemocompatibility with long-term mechanical circulatory support devices
  • Review outcomes of current mechanical devices versus cardiac transplant
  • Describe various approaches to expand the pool of available cardiac transplant donors
  • Review the use of molecular diagnostic testing to non-invasively detect cardiac allograft rejection